tiprankstipranks
Trending News
More News >
Zelira Therapeutics Ltd. (ZLDAF)
:ZLDAF
US Market

Zelira Therapeutics (ZLDAF) Income Statement

Compare
16 Followers

Zelira Therapeutics Income Statement

Last quarter (Q4 2025), Zelira Therapeutics's total revenue was AU$0.00, a decrease of -100.00% from the same quarter last year. In Q4, Zelira Therapeutics's net income was AU$-1.22M. See Zelira Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
AU$ 656.00AU$ 94.95KAU$ 301.12KAU$ 1.54MAU$ 663.32K
Gross Profit
AU$ -802.95KAU$ 10.28KAU$ -3.22MAU$ -5.72MAU$ -39.16K
Operating Expenses
AU$ 3.15MAU$ 5.95MAU$ 6.17MAU$ 7.70MAU$ 9.61M
Depreciation and Amortization
AU$ 147.05KAU$ 479.04KAU$ 545.22KAU$ 588.54KAU$ 474.25K
EBITDA
AU$ -4.17MAU$ -36.44MAU$ -6.79MAU$ -13.06MAU$ -9.41M
Operating Income
AU$ -3.95MAU$ -5.94MAU$ -7.41MAU$ -13.41MAU$ -9.65M
Other Income/Expenses
AU$ 102.52KAU$ -30.80MAU$ 1.29KAU$ -290.82KAU$ -275.31K
Pretax Income
AU$ -3.85MAU$ -36.74MAU$ -7.41MAU$ -13.71MAU$ -9.93M
Net Income
AU$ -3.63MAU$ -36.57MAU$ -5.57MAU$ -11.95MAU$ -8.55M
Per Share Metrics
Basic EPS
AU$ -0.32AU$ -3.22AU$ -0.55AU$ -1.49AU$ -1.29
Diluted EPS
AU$ -0.32AU$ -3.22AU$ -0.55AU$ -1.49AU$ -1.29
Weighted Average Shares Outstanding
11.48M 11.35M 10.07M 8.04M 6.63M
Weighted Average Shares Outstanding (Diluted)
11.48M 11.35M 10.07M 8.04M 6.63M
Currency in AUD

Zelira Therapeutics Earnings and Revenue History